Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol?

O. Regnier-Gavier,P. Coliat,H. Carinato,M. Burgy,D. Exinger,C. Fischbach, M. Kalish-Weindling, R. Ferry,H. Flesch,G. Bronner,P. Hemar, P. Schultz,D. Prebay,C. Borel

EUROPEAN JOURNAL OF CANCER(2017)

引用 3|浏览18
暂无评分
关键词
Cetuximab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要